Mark A. Preston
Impact in
Papers in
- Surgery 73
- Bladder and Urothelial Cancer Treatments 60
- Urinary and Genital Oncology Studies 40
-
- Prostate Cancer Treatment and Research 29
- Prostate Cancer Diagnosis and Treatment 21
- Co-authors
- Quoc‐Dien Trinh (37 shared papers)Adam S. Kibel (54 shared papers)Toni K. Choueiri (23 shared papers)Mani Menon (11 shared papers)Joaquim Bellmunt (17 shared papers)Steven L. Chang (24 shared papers)Maxine Sun (13 shared papers)Thomas Seisen (12 shared papers)
- Journals
- Journal of Clinical Oncology (24 papers)The Journal of Urology (13 papers)Urologic Oncology Seminars and Original Investigations (11 papers)European Urology (9 papers)Clinical Genitourinary Cancer (4 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Mark A. Preston
117 papers receiving 2.7k citations
Mark A. Preston's Hit Papers
Peers
Comparison fields: 5 of 117
- Urology 386
- Surgery 1.6k
- Pulmonary and Respiratory Medicine 1.1k
- Oncology 615
- Rheumatology 305
Countries citing papers authored by Mark A. Preston
This map shows the geographic impact of Mark A. Preston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Preston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Preston more than expected).
Fields of papers citing papers by Mark A. Preston
This network shows the impact of papers produced by Mark A. Preston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Preston. The network helps show where Mark A. Preston may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Preston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY) Hit paper breakdown → | 2021 | 244 |
| 2 | 2016 | 161 | |
| 3 | 2017 | 121 | |
| 4 | 2005 | 120 | |
| 5 | 2020 | 89 | |
| 6 | 2017 | 88 | |
| 7 | 2018 | 87 | |
| 8 | 2015 | 79 | |
| 9 | 2016 | 77 | |
| 10 | 2018 | 76 | |
| 11 | 2015 | 67 | |
| 12 | 2016 | 65 | |
| 13 | 2017 | 62 | |
| 14 | 2017 | 60 | |
| 15 | 2013 | 58 | |
| 16 | 2018 | 51 | |
| 17 | 2018 | 50 | |
| 18 | 2017 | 49 | |
| 19 | 2019 | 49 | |
| 20 | 2020 | 48 |
About Mark A. Preston
Mark A. Preston is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Urology and Radiology, Nuclear Medicine and Imaging, having authored 123 papers that have together received 2.7k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (60 papers), Urinary and Genital Oncology Studies (40 papers), Prostate Cancer Treatment and Research (29 papers), Prostate Cancer Diagnosis and Treatment (21 papers), Urological Disorders and Treatments (16 papers), Radiopharmaceutical Chemistry and Applications (11 papers), Cancer, Lipids, and Metabolism (10 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Urology (386 citations), Surgery (1.6k citations), Pulmonary and Respiratory Medicine (1.1k citations), Oncology (615 citations) and Rheumatology (305 citations). Mark A. Preston has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Quoc‐Dien Trinh, Adam S. Kibel, Toni K. Choueiri, Mani Menon, Joaquim Bellmunt, Steven L. Chang, Maxine Sun, Thomas Seisen, Jeffrey J. Leow and Alexander P. Cole. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Urologic Oncology Seminars and Original Investigations, European Urology and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.